Janux Therapeutics Inc (JANX)

Finanzdaten der Janux Therapeutics Inc-Aktie (JANX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	175.03%10.27	3.73	-	10.00	-
	15.59%30.99	26.81	-	-	34.66
Research and Development	15.59%30.99	26.81	-	-	34.66
Operating Income/Loss	7.37%-31.69	-34.21	-42.40	-35.25	-45.12
Nonoperating Income/Loss	1.36%9.72	9.85	10.46	10.94	11.26
	9.81%-21.97	-24.36	-31.95	-24.31	-33.86
Attributable To Parent	9.81%-21.97	-24.36	-31.95	-24.31	-33.86
Basic Average Shares	0.43%62.94	62.67	0.06	62.02	61.90
Diluted Average Shares	0.43%62.94	62.67	0.06	62.02	61.90
Basic Earnings Per Share	10.26%-0.35	-0.39	-0.51	-0.39	-0.55
Diluted Earnings Per Share	10.26%-0.35	-0.39	-0.51	-0.39	-0.55